July 24, 2024 / 10:38 IST
Reported Standalone quarterly numbers for Torrent Pharmaceuticals are:Net Sales at Rs 2,438.00 crore in June 2024 up 14.95% from Rs. 2,121.00 crore in June 2023.
Quarterly Net Profit at Rs. 469.00 crore in June 2024 up 45.2% from Rs. 323.00 crore in June 2023.
EBITDA stands at Rs. 920.00 crore in June 2024 up 22.99% from Rs. 748.00 crore in June 2023.
Torrent Pharma EPS has increased to Rs. 13.86 in June 2024 from Rs. 9.55 in June 2023.
| Torrent Pharma shares closed at 3,138.70 on July 23, 2024 (NSE) and has given 25.88% returns over the last 6 months and 61.71% over the last 12 months. |
| Torrent Pharmaceuticals | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 2,394.00 | 2,143.00 | 2,121.00 | | Other Operating Income | 44.00 | -- | -- | | Total Income From Operations | 2,438.00 | 2,143.00 | 2,121.00 | | EXPENDITURE | | Consumption of Raw Materials | 410.00 | 409.00 | 434.00 | | Purchase of Traded Goods | 141.00 | 168.00 | 113.00 | | Increase/Decrease in Stocks | 32.00 | -39.00 | -40.00 | | Power & Fuel | -- | -- | -- | | Employees Cost | 406.00 | 353.00 | 369.00 | | Depreciation | 189.00 | 195.00 | 183.00 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 550.00 | 536.00 | 508.00 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 710.00 | 521.00 | 554.00 | | Other Income | 21.00 | 76.00 | 11.00 | | P/L Before Int., Excpt. Items & Tax | 731.00 | 597.00 | 565.00 | | Interest | 64.00 | 67.00 | 90.00 | | P/L Before Exceptional Items & Tax | 667.00 | 530.00 | 475.00 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 667.00 | 530.00 | 475.00 | | Tax | 198.00 | 120.00 | 152.00 | | P/L After Tax from Ordinary Activities | 469.00 | 410.00 | 323.00 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 469.00 | 410.00 | 323.00 | | Equity Share Capital | 169.23 | 169.23 | 169.23 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 13.86 | 12.12 | 9.55 | | Diluted EPS | 13.86 | 12.12 | 9.55 | | EPS After Extra Ordinary | | Basic EPS | 13.86 | 12.12 | 9.55 | | Diluted EPS | 13.86 | 12.12 | 9.55 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
